Αποτελέσματα Αναζήτησης
Symptomatic vaginal bleeding and postmenopausal status in women with endometrial polyps increased the risk of malignancy. This finding could be an useful evidence to select patients who need to undergo hysteroscopic resection of endometrial polyps and women to whom, instead, an expectant management …
- Endometrial polyps: Pathogenesis, sequelae and treatment
The risk factors for endometrial polyp formation include...
- Risk and predictors of malignancy in women with endometrial polyps
The risk of endometrial cancer in women with endometrial...
- Endometrial polyps: Pathogenesis, sequelae and treatment
Symptomatic vaginal bleeding and postmenopausal status in women with endometrial polyps increased the risk of malignancy. This finding could be an useful evidence to select patients who need to undergo hysteroscopic resection of endometrial polyps and women to whom, instead, an expectant management can be offer. Keywords. Uterine polyps.
21 Οκτ 2024 · This study aims to examine cases identified with endometrial polyp and carcinoma originating from polyps in patients presenting with gynaecological problems, and to highlight the significance of risk factors contributing to malignancy.
The risk of endometrial cancer in women with endometrial polyps is 1.3%, while cancers confined to a polyp were found in only 0.3%. The risk is greatest in postmenopausal women with vaginal bleeding.
The risk of hyperplasia and cancer in polyps with an endometrial thickness ≥ 10.8 mm on TVUS was found 5.5-fold higher in a class II study, confirming that a thickened endometrium in postmenopausal women should be further investigated, ideally with hysteroscopic-guided biopsy .
24 Ιουν 2011 · Endometrial polyps commonly affect premenopausal and postmenopausal women and carry a small risk of cancer. Consensus guidelines to direct the management of women with endometrial polyps are lacking. We examined the risk of malignancy in symptomatic and asymptomatic women with endometrial polyps.
The risk factors for endometrial polyp formation include increased endogenous oestrogen and exogenous oestrogen administration. Tamoxifen (a uterine oestrogen agonist used to treat breast cancer in pre- and postmenopausal women) have an increased likelihood of developing endometrial polyp. 27
